Stan N. Finkelstein

2.5k total citations · 1 hit paper
50 papers, 1.8k citations indexed

About

Stan N. Finkelstein is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Stan N. Finkelstein has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 8 papers in General Health Professions and 6 papers in Epidemiology. Recurrent topics in Stan N. Finkelstein's work include Influenza Virus Research Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Workplace Health and Well-being (4 papers). Stan N. Finkelstein is often cited by papers focused on Influenza Virus Research Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Workplace Health and Well-being (4 papers). Stan N. Finkelstein collaborates with scholars based in United States, Portugal and United Kingdom. Stan N. Finkelstein's co-authors include Ernst R. Berndt, Iain Cockburn, Randall S. Stafford, Howard L. Bailit, Nancy G. Leveson, Jai Raman, Bruce A. Chabner, Bernardo H. L. Goulart, Jeffrey W. Clark and Thomas G. Roberts and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Management Science.

In The Last Decade

Stan N. Finkelstein

50 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Economic burden of depression

1994 769 citations Stan N. Finkelstein, Ernst R. Berndt et al. profile →

Peers

Stan N. Finkelstein

GHP

PHARM

PMH

Antonio Pardo Spain

Michael Kirby United Kingdom

James S. Roberts United States

Paula A. Goldman United States

Anneli Ojajärvi Finland

S. Pampallona Switzerland

Susan J. Blalock United States

Catherine Beverley United Kingdom

Judit Simon Austria

Melony E. Sorbero United States

Antonio Pardo Spain

Stan N. Finkelstein

435 ×1.0

393 ×1.1

GHP

129 ×0.4

PHARM

219 ×0.7

PMH

608 ×2.2

Citations per year, relative to Stan N. Finkelstein Stan N. Finkelstein (= 1×) peers Antonio Pardo

Countries citing papers authored by Stan N. Finkelstein

Since Specialization

Citations

This map shows the geographic impact of Stan N. Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan N. Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan N. Finkelstein more than expected).

Fields of papers citing papers by Stan N. Finkelstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan N. Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan N. Finkelstein. The network helps show where Stan N. Finkelstein may publish in the future.

Co-authorship network of co-authors of Stan N. Finkelstein

This figure shows the co-authorship network connecting the top 25 collaborators of Stan N. Finkelstein. A scholar is included among the top collaborators of Stan N. Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan N. Finkelstein. Stan N. Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Welsch, Roy E., et al.. (2025). Alzheimer’s disease risk prediction using machine learning for survival analysis with a comorbidity-based approach. Scientific Reports. 15(1). 28723–28723. 1 indexed citations

Zheng, Bang, et al.. (2024). Can metformin prevent cancer relative to sulfonylureas? A target trial emulation accounting for competing risks and poor overlap via double/debiased machine learning estimators. American Journal of Epidemiology. 194(2). 512–523. 2 indexed citations

Lu, Haiyan, et al.. (2022). Systematically exploring repurposing effects of antihypertensives. Pharmacoepidemiology and Drug Safety. 31(9). 944–952. 5 indexed citations

Figueiredo, Lígia, Eric C. Makhni, Meghan Dierks, Frederico Castelo Ferreira, & Stan N. Finkelstein. (2021). Early cost estimating model for new bioabsorbable orthopedic implant candidates: A theoretical study. Journal of the mechanical behavior of biomedical materials. 124. 104731–104731. 3 indexed citations

Cabral, Joaquim M. S., et al.. (2019). Economics of Beta-Cell Replacement Therapy. Current Diabetes Reports. 19(9). 75–75. 9 indexed citations

Raman, Jai, et al.. (2016). When a checklist is not enough: How to improve them and what else is needed. Journal of Thoracic and Cardiovascular Surgery. 152(2). 585–592. 23 indexed citations

D’Ambrosio, Lisa, et al.. (2016). Preventive behaviors and perceptions of influenza vaccination among a university student population. Journal of Public Health. 38(4). fdv189–fdv189. 13 indexed citations

Finkelstein, Stan N., et al.. (2015). Engineering Effective Responses to Influenza Outbreaks. Service Science. 7(2). 119–131. 4 indexed citations

Finkelstein, Stan N., Shiva Prakash, Karima Nigmatulina, James McDevitt, & Richard C. Larson. (2011). A Home Toolkit for Primary Prevention of Influenza by Individuals and Families. Disaster Medicine and Public Health Preparedness. 5(4). 266–271. 2 indexed citations

10.

Lyman, Gary H., Ernst R. Berndt, Joel Kallich, et al.. (2005). The Economic Burden of Anemia in Cancer Patients Receiving Chemotherapy. Value in Health. 8(2). 149–156. 58 indexed citations

11.

Pransky, Glenn, Ernst R. Berndt, Stan N. Finkelstein, Santosh K. Verma, & Amit Agrawal. (2005). Performance Decrements Resulting From Illness in the Workplace: The Effect of Headaches. Journal of Occupational and Environmental Medicine. 47(1). 34–40. 16 indexed citations

12.

Ozminkowski, Ronald J., William D. Marder, Kevin Hawkins, et al.. (2004). The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans. Clinical Therapeutics. 26(8). 1341–1354. 16 indexed citations

13.

Ma, Jun, Randall S. Stafford, Iain Cockburn, & Stan N. Finkelstein. (2003). A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clinical Therapeutics. 25(5). 1503–1517. 40 indexed citations

14.

Crown, William H., Ernst R. Berndt, Onur Baser, Stan N. Finkelstein, & Whitney P. Witt. (2003). Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter?. Forum for Health Economics & Policy. 7(1). 95–127. 4 indexed citations

15.

Stafford, Randall S., Jun Ma, Stan N. Finkelstein, Kenan Haver, & Iain Cockburn. (2003). National trends in asthma visits and asthma pharmacotherapy, 1978-2002. Journal of Allergy and Clinical Immunology. 111(4). 729–735. 66 indexed citations

16.

Stafford, Randall S., et al.. (2001). National Patterns of Medication Treatment for Depression, 1987 to 2001. The Primary Care Companion For CNS Disorders. 3(6). 232–235. 79 indexed citations

17.

Cockburn, Iain, Howard L. Bailit, Ernst R. Berndt, & Stan N. Finkelstein. (1999). Loss of Work Productivity due to Illness and Medical Treatment. Journal of Occupational and Environmental Medicine. 41(11). 948–953. 119 indexed citations

18.

RN, Stan N. Finkelstein, & Ernst R. Berndt. (1995). Economic Consequences of Illness in the Workplace. 36(4). 26–38. 35 indexed citations

19.

Finkelstein, Stan N., et al.. (1994). Medical Cost Savings from Pentoxifylline Therapy in Chronic Occlusive Arterial Disease. PharmacoEconomics. 5(2). 130–140. 3 indexed citations

20.

Finkelstein, Stan N., et al.. (1982). The American blood supply. DigitalGeorgetown (Georgetown University Library). 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact